RFG Advisory’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,948
Closed -$372K 417
2019
Q4
$372K Sell
1,948
-1,689
-46% -$305K 0.06% 243
2019
Q3
$612K Buy
3,637
+646
+22% +$105K 0.12% 147
2019
Q2
$500K Buy
+2,991
New +$414K 0.11% 161
2016
Q1
Sell
-1,088
Closed -$340K 97
2015
Q4
$340K Sell
1,088
-857
-44% -$255K 0.25% 36
2015
Q3
$529K Buy
1,945
+395
+25% +$121K 1.7% 10
2015
Q2
$470K Buy
1,550
+458
+42% +$137K 0.21% 73
2015
Q1
$314K Buy
1,092
+65
+6% +$18.5K 0.24% 29
2014
Q4
$264K Buy
+1,027
New +$257K 0.31% 20

Other funds holding AGN

RFG Advisory's AGN Position: Q1 2020 in Review

RFG Advisory sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,948 shares — an estimated $372K sold.

RFG Advisory first reported a position in AGN in Q4 2014 and held it in 8 quarters. The position peaked at $612K in Q3 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • RFG Advisory reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • RFG Advisory sold 1,948 Allergan plc shares in Q1 2020, an estimated $372K.
  • RFG Advisory first reported a position in Allergan plc in Q4 2014 and held it in 8 quarters.
  • RFG Advisory's Allergan plc position peaked at $612K in Q3 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on RFG Advisory's 13F filing for Q1 2020, filed 17 Apr 2020.